ONYX PHARMACEUTICALS INC
S-3, EX-23.1, 2000-09-22
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ONYX PHARMACEUTICALS INC, S-3, EX-5.1, 2000-09-22
Next: AVIATION SALES CO, 8-K, 2000-09-22



<PAGE>
                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Onyx
Pharmaceuticals, Inc. for the registration of 3,000,000 shares of its common
stock and to the incorporation by reference therein of our report dated
February 18, 2000, with respect to the financial statements of Onyx
Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year
ended December 31, 1999, filed with the Securities and Exchange Commission.

                                                           /S/ ERNST & YOUNG LLP

Palo Alto, California
September 20, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission